These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33639941)

  • 1. Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk.
    Sevilla-González MDR; Merino J; Moreno-Macias H; Rojas-Martínez R; Gómez-Velasco DV; Manning AK
    Cardiovasc Diabetol; 2021 Feb; 20(1):56. PubMed ID: 33639941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
    Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
    Alizadeh Z; Baradaran HR; Kohansal K; Hadaegh F; Azizi F; Khalili D
    Front Endocrinol (Lausanne); 2022; 13():1041808. PubMed ID: 36277718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonlinear association between remnant cholesterol and reversion from impaired fasting glucose to normoglycemia: a multicenter cohort study.
    Kong L; Wu Y; Yang H; Guo M; Zhong Y; Li J; Wu S; Xiong Z
    Lipids Health Dis; 2024 Sep; 23(1):303. PubMed ID: 39300559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes.
    Tsur A; Feldman BS; Feldhammer I; Hoshen MB; Leibowitz G; Balicer RD
    Diabetes Care; 2013 May; 36(5):1361-7. PubMed ID: 23393216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term maternal cardiometabolic outcomes 22 years after gestational diabetes mellitus.
    Tutino GE; Tam CH; Ozaki R; Yuen LY; So WY; Chan MH; Ko GT; Yang X; Chan JC; Tam WH; Ma RC
    J Diabetes Investig; 2020 Jul; 11(4):985-993. PubMed ID: 31912653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort.
    Arellano-Campos O; Gómez-Velasco DV; Bello-Chavolla OY; Cruz-Bautista I; Melgarejo-Hernandez MA; Muñoz-Hernandez L; Guillén LE; Garduño-Garcia JJ; Alvirde U; Ono-Yoshikawa Y; Choza-Romero R; Sauque-Reyna L; Garay-Sevilla ME; Malacara-Hernandez JM; Tusie-Luna MT; Gutierrez-Robledo LM; Gómez-Pérez FJ; Rojas R; Aguilar-Salinas CA
    BMC Endocr Disord; 2019 Apr; 19(1):41. PubMed ID: 31030672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.
    Ferrannini E; Massari M; Nannipieri M; Natali A; Ridaura RL; Gonzales-Villalpando C
    Diabetologia; 2009 May; 52(5):818-24. PubMed ID: 19224196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
    Jadhakhan F; Marshall T; Ryan R; Gill P
    BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study.
    Li Y; Feng D; Esangbedo IC; Zhao Y; Han L; Zhu Y; Fu J; Li G; Wang D; Wang Y; Li M; Gao S; Willi SM
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
    Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population: CA.ME.LI.A study 7 years follow-up.
    Bignotto M; Bianco E; Centofanti L; Russo A; Dei Cas M; Zermiani P; Morano C; Samartin F; Bertolini E; Bifari F; Berra C; Zuin M; Paroni R; Battezzati PM; Folli F
    Am J Physiol Endocrinol Metab; 2024 Oct; 327(4):E498-E511. PubMed ID: 39196799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study.
    Kramer CK; von Mühlen D; Jassal SK; Barrett-Connor E
    Diabetes Care; 2009 Jul; 32(7):1272-3. PubMed ID: 19366963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APPLICATION OF THE AACE/ACE ADVANCED FRAMEWORK FOR THE DIAGNOSIS OF OBESITY AND CARDIOMETABOLIC DISEASE STAGING IN A GENERAL POPULATION FROM 3 REGIONS OF VENEZUELA: THE VEMSOLS STUDY RESULTS.
    Nieto-Martínez R; González-Rivas JP; Ugel E; Brajkovich I; Risquez A; Garvey WT; Mechanick JI
    Endocr Pract; 2018 Jan; 24(1):6-13. PubMed ID: 29106817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does elevated plasma triglyceride level independently predict impaired fasting glucose?: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Lin SX; Berlin I; Younge R; Jin Z; Sibley CT; Schreiner P; Szklo M; Bertoni AG
    Diabetes Care; 2013 Feb; 36(2):342-7. PubMed ID: 23033247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of traits of metabolic syndrome with glucose abnormalities.
    Hoffmann IS; Cubeddu LX
    Am J Ther; 2013; 20(4):363-8. PubMed ID: 23591026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.